Membership Criteria

Membership of EPAG is open to “European Pharmaceutical Companies that develop new products for human use utilising the Pulmonary or Nasal route of delivery”.  A Pharmaceutical Company is a company responsible for the development of the product. It would normally have its own Research and/or Development capability, and the capability to submit, applications for product licenses.  It is recognised that product development will take place in collaboration with other Pharmaceutical companies as well as non-Pharmaceutical companies (e.g. Active Pharmaceutical Ingredient (API) suppliers, device design and componentry manufacturers, consultants etc). These non-Pharmaceutical companies may be invited to attend when a particular need is identified.  Companies, including non-European companies, may be admitted as members where they provide specific expertise that supports and enhances EPAG objectives.